Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.
53
0
Despite a fall in prescription numbers for low-value treatments, the overall cost of prescribing these items in English primary care has risen, according to new research published by the Journal of the Royal Society of Medicine. ...
4
0
(HealthDay)—Patterns of potential opioid misuse are positively associated with subsequent opioid overdose, according to a study published online May 22 in the Annals of Internal Medicine.
4
0
Prescription cough and cold medicines containing the opioid hydrocodone were more likely to cause serious side effects in children than those containing codeine, according to a new study from Penn State College of Medicine. ...
4
0
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.
13
0
A study published in the American Journal of Preventive Medicine sheds new light on the sharp rise in fatal drug overdoses in recent years, one of the most severe public health challenges of our time. The study found that ...
3
0
(HealthDay)—Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure.
13
0
(HealthDay)—Patients undergoing urological procedures use just over half of their initial prescription of opioids, on average, according to a study presented at the annual meeting of the American Urological Association, ...
2
0
According to the University of Pittsburgh School of Medicine scientists who conducted the study, theirs is the first large-scale evaluation of the impact of in-hospital opioid prescribing on post-discharge opioid use.
5
0
(HealthDay)—Lucemyra (lofexidine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat symptoms of opioid withdrawal.
4
0
